Literature DB >> 7151655

Treatment of severe lactic acidosis with dichloroacetate.

P J Blackshear, L S Fang, L Axelrod.   

Abstract

Four patients with severe lactic acidosis associated with septic shock were treated with sodium dichloroacetate (DCA) (50 mg/kg body wt), an activator of pyruvate dehydrogenase. All patients were in a group with an expected mortality rate of 90-100%, based on previous studies. In one patient, treatment with DCA was associated with a decrease in blood lactate levels from 11.2 mM before treatment to 0.8 mM 16 h later. Markedly elevated blood pyruvate and alanine levels also decreased to normal. After treatment, the arterial blood pH rose to 7.53, and vasopressor agents were no longer needed to support blood pressure. Some degree of biochemical improvement was also noted in the other cases in whom the blood lactate levels before treatment were 15, 17, and 31 mM. However, all three patients eventually died of refractory acidosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7151655     DOI: 10.2337/diacare.5.4.391

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  3 in total

1.  Bicarbonate haemodialysis: an adequate treatment for lactic acidosis in diabetics treated by metformin.

Authors:  J D Lalau; P F Westeel; X Debussche; H Dkissi; M Tolani; B Coevoet; B Temperville; A Fournier; J Quichaud
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

2.  Lipopolysaccharide (LPS)-induced septic shock causes profound changes in myocardial energy metabolites in pigs.

Authors:  Joaquin Lado-Abeal; Noelia Martinez-Sánchez; Jose Angel Cocho; Manuel Martín-Pastor; Isabel Castro-Piedras; M Luz Couce-Pico; Asish K Saha; Miguel López
Journal:  Metabolomics       Date:  2018-09-25       Impact factor: 4.290

3.  Dichloroacetate improves mitochondrial function, physiology, and morphology in FBXL4 disease models.

Authors:  Manuela Lavorato; Eiko Nakamaru-Ogiso; Neal D Mathew; Elizabeth Herman; Nina Shah; Suraiya Haroon; Rui Xiao; Christoph Seiler; Marni J Falk
Journal:  JCI Insight       Date:  2022-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.